Allt inom Interim
Nanexa publishes interim report for January – June 2023
Strong preclinical progress with NEX-22, positive Phase 1 data with NEX-20 and several partner projects in preclinical evaluation
Nanexa publishes interim report for January – March 2023
Positive pre-clinical data with NEX-22, NEX-20 phase I continues and good progress in partner projects